Aster DM Quality Care Reports ₹1,310.68 Crore Consolidated Revenue Post-Merger

Consolidated Revenue: ₹1,310.68 crore
Standalone Net Profit/(Loss): (₹14.30 crore)

Reader Takeaway: Consolidated revenue shows growth; standalone loss is due to one-time merger costs.

What just happened

Aster DM Quality Care Limited, formerly Aster DM Healthcare Limited, announced its financial results for the first quarter ended June 30, 2026. The company's merger with Quality Care India Limited became effective on July 1, 2026. Consolidated revenue from operations for Q1 FY27 stood at ₹1,310.68 crore, while the standalone net profit/(loss) was (₹14.30 crore).

Why this matters

The reported standalone net loss was significantly influenced by exceptional items amounting to ₹109.79 crore. These expenses are related to professional fees and other costs associated with the merger. Investors should note that the consolidated figures reflect the combined operational performance, while the standalone results include these one-time merger expenses.

The backstory

The merger of Quality Care India Limited with Aster DM Quality Care Limited was sanctioned by the National Company Law Tribunal (NCLT). The effective date of this amalgamation was July 1, 2026. Following this, the company officially changed its name from Aster DM Healthcare Limited to Aster DM Quality Care Limited.

What changes now

With the merger effective, future financial reporting will consolidate the operations of both entities. This means that the reported figures will increasingly reflect the scale and performance of the combined business. The company also made strategic investments, acquiring an additional 1.54% stake in Malabar Institute of Medical Sciences Limited for ₹31.40 crore, increasing its holding to 81.29%. Further capital was allocated to Aster DM-Super Specialty Hospital (Sarjapur) for ₹45.09 crore and Alfaone Medicals Private Limited for ₹25.00 crore.

Risks to watch

The primary risk for investors is discerning the true operational performance from the one-time costs associated with the merger. Successful integration of the merged entities and realization of expected synergies will be crucial for future growth.

Peer comparison

N/A

Context metrics (time-bound)

• Consolidated Revenue (Q1 FY27): ₹1,310.68 crore
• Standalone Net Profit/(Loss) (Q1 FY27): (₹14.30 crore)
• Merger-related exceptional costs: ₹109.79 crore
• Effective date of merger: July 1, 2026

What to track next

Investors should closely monitor the financial results in the upcoming quarters to assess the integration of the merged entities and the impact of synergies. Management commentary on future strategies and operational efficiencies will be key.